<i>In vitro</i>, TRIM25 silencing suppressed liver cancer cell proliferation and increased ferroptosis-related phenotypes, as indicated by increased ferrous iron and MDA levels, reduced GSH content and SOD activity, and elevated ROS and lipid peroxidation. Here, SOD1 is linked to liver cancer.